Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00510237 · ClinicalTrials.gov registry record · NA
Intervention for Newly Diagnosed Youth With HIV
A NA study of HIV, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 4
- Study locations
NCT00510237: Completed NA study of HIV, sponsored by University of North Carolina, Chapel Hill.
NCT00510237 is a NA study of HIV that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 50 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (89% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00510237, a NA study of HIV, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study will pilot test an HIV intervention for newly diagnosed youth (diagnosed for less than 15 months) to assess its acceptability and feasibility preliminary to and leading up to a full-scale, randomized trial. The general focus of the intervention is to aid in the psychosocial adjustment of adolescents who have recently been diagnosed with HIV.
Conditions Studied
Interventions
- BEHAVIORAL "Adolescents Coping, Connecting, Empowering, and Protecting Together" (Project ACCEPT)
Study Locations (4)
Florida
- University of Miami School of Medicine - Miami
Illinois
- John Stroger Jr. Hospital of Cook County - Chicago
New York
- Montefiore Medical Center - The Bronx
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-01 |
| Phase | NA |
What the finished NCT00510237 record still lists
NCT00510237 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (89% lower).
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which "Adolescents Coping, Connecting, Empowering, and Protecting Together" (Project ACCEPT) is the first listed.
NCT00510237 reports a single indexed study location in Florida, Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT00510237 about?
NCT00510237 is a clinical study titled "Intervention for Newly Diagnosed Youth With HIV". This study will pilot test an HIV intervention for newly diagnosed youth (diagnosed for less than 15 months) to assess its acceptability and feasibility preliminary to and leading up to a full-scale, randomized trial. The general focus of the intervention is to aid in the psychosocial adjustment of ...
What is the current status of trial NCT00510237?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2007-02. Estimated completion is 2009-01.
What conditions does trial NCT00510237 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT00510237?
The interventions under investigation include: "Adolescents Coping, Connecting, Empowering, and Protecting Together" (Project ACCEPT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00510237?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00510237 being conducted?
This trial has 4 study locations across Florida, Illinois, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00510237's enrollment target sits among peer trials
50 219th of 303 higher than 73 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
- NCT01746836 · 50 participants · Phase 2
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia